Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-07

Clinical Trial Update: Effect of Recombinant Human Interferon α-2b Spray on Herpangina [Phase 4]

View source ↗

Summary

Phase 4 trial update on recombinant human interferon α-2b spray for herpangina has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon α-2b spray (interferon alpha-2b)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Herpangina | Phase 4 | Status: COMPLETED